Previous studies indicate downregulation of Bcl-2 in the presence of DATS in human pancreatic (Ma et al. 2014), epithelial ovarian (Wan et al. 2013), leukemia (Choi and Park 2012), lung (Li et al. 2012), breast (Malki et al. 2009), and prostate (Kim et al. 2007) cancer cell lines. This evidence concerns the gene BCL2 and cancer.